Efficient gene transfer into spleen cells of newborn mice by a replication-competent retroviral vector
- PMID: 11886253
- DOI: 10.1006/viro.2001.1284
Efficient gene transfer into spleen cells of newborn mice by a replication-competent retroviral vector
Abstract
A murine leukemia virus-derived replication-competent retroviral vector with a translational cassette for the enhanced green fluorescence protein (EGFP) was previously found to function efficiently in cell culture (Jespersen et al., 1999, Gene 239, 227-235). We here report that infection of newborn NIH Swiss mice gives rise to EGFP expression in a majority of spleen cells within the first days after infection. Among the nonadherent spleen cells, B, T, and NK lymphocytes were found to be efficiently marked by EGFP by flow cytometry analysis, whereas the adherent spleen cells were negative in most animals. Analysis at time points up to 60 days after infection reveals a decline in EGFP-positive spleen cells over time. Viremia analysis and PCR analysis of spleen DNA indicate that viruses that have lost the translation cassette predominate at later stages. The results provide a model for efficient gene delivery to spleen cells in a time window of 1 to 2 weeks after infection of newborns. Although this type of vector will not in itself be applicable in the clinic, we envision that efficient in vivo gene delivery will be valuable by analysis of differentiation and proliferation of hematopoietic cells in animal models and by development and evaluation of effectors interfering with these processes.
Similar articles
-
Gene transfer in ovarian cancer cells: a comparison between retroviral and lentiviral vectors.Cancer Res. 2002 Nov 1;62(21):6099-107. Cancer Res. 2002. PMID: 12414634
-
Enhanced transgene expression in primitive hematopoietic progenitor cells and embryonic stem cells efficiently transduced by optimized retroviral hybrid vectors.Gene Ther. 2002 Apr;9(8):477-87. doi: 10.1038/sj.gt.3301653. Gene Ther. 2002. PMID: 11948372
-
Retroviral transfer and expression of a humanized, red-shifted green fluorescent protein gene into human tumor cells.Nat Biotechnol. 1996 May;14(5):610-4. doi: 10.1038/nbt0596-610. Nat Biotechnol. 1996. PMID: 9630952
-
Quantitative evaluation of the murine B16 melanoma tumor model after gene marking with an EGFP/Neo expressing retroviral vector.In Vivo. 2002 May-Jun;16(3):167-74. In Vivo. 2002. PMID: 12182111
-
Transgene stability for three replication-competent murine leukemia virus vectors.Gene. 2004 Mar 31;329:61-9. doi: 10.1016/j.gene.2003.12.032. Gene. 2004. PMID: 15033529
Cited by
-
The AKV murine leukemia virus is restricted and hypermutated by mouse APOBEC3.J Virol. 2009 Nov;83(22):11550-9. doi: 10.1128/JVI.01430-09. Epub 2009 Sep 2. J Virol. 2009. PMID: 19726503 Free PMC article.
-
An RNA secondary structure bias for non-homologous reverse transcriptase-mediated deletions in vivo.Nucleic Acids Res. 2004 Apr 6;32(6):2039-48. doi: 10.1093/nar/gkh513. Print 2004. Nucleic Acids Res. 2004. PMID: 15069126 Free PMC article.
-
Adenovirus-retrovirus hybrid vectors achieve highly enhanced tumor transduction and antitumor efficacy in vivo.Mol Ther. 2011 Jan;19(1):76-82. doi: 10.1038/mt.2010.182. Epub 2010 Aug 31. Mol Ther. 2011. PMID: 20808291 Free PMC article.
-
Effects of viral strain, transgene position, and target cell type on replication kinetics, genomic stability, and transgene expression of replication-competent murine leukemia virus-based vectors.J Virol. 2007 Jul;81(13):6973-83. doi: 10.1128/JVI.02470-06. Epub 2007 Apr 18. J Virol. 2007. PMID: 17442710 Free PMC article.
-
DNA-based therapeutics and DNA delivery systems: a comprehensive review.AAPS J. 2005 Apr 8;7(1):E61-77. doi: 10.1208/aapsj070109. AAPS J. 2005. PMID: 16146351 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources